

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-mediated cell contraction (GO:0070252) | 9.94888512 |
| 2 | skeletal muscle fiber development (GO:0048741) | 8.35232688 |
| 3 | actin filament-based movement (GO:0030048) | 7.43781129 |
| 4 | glycogen catabolic process (GO:0005980) | 7.24008587 |
| 5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.20706585 |
| 6 | myotube cell development (GO:0014904) | 7.11454291 |
| 7 | purine nucleotide salvage (GO:0032261) | 7.01731868 |
| 8 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.85498223 |
| 9 | glucan catabolic process (GO:0009251) | 6.77901086 |
| 10 | striated muscle atrophy (GO:0014891) | 6.68682788 |
| 11 | creatine metabolic process (GO:0006600) | 6.58151775 |
| 12 | plasma membrane repair (GO:0001778) | 6.47085342 |
| 13 | sarcomere organization (GO:0045214) | 6.45781085 |
| 14 | skeletal muscle tissue regeneration (GO:0043403) | 6.44576917 |
| 15 | striated muscle contraction (GO:0006941) | 6.42609229 |
| 16 | carnitine shuttle (GO:0006853) | 6.36534843 |
| 17 | cellular polysaccharide catabolic process (GO:0044247) | 6.33624094 |
| 18 | polysaccharide catabolic process (GO:0000272) | 6.05606861 |
| 19 | response to muscle activity (GO:0014850) | 6.03782135 |
| 20 | IMP metabolic process (GO:0046040) | 5.82583703 |
| 21 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.81067993 |
| 22 | muscle atrophy (GO:0014889) | 5.78752712 |
| 23 | myofibril assembly (GO:0030239) | 5.75788720 |
| 24 | striated muscle adaptation (GO:0014888) | 5.61061700 |
| 25 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.58361354 |
| 26 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.55034467 |
| 27 | regulation of cell communication by electrical coupling (GO:0010649) | 5.54037392 |
| 28 | response to inactivity (GO:0014854) | 5.50526086 |
| 29 | muscle contraction (GO:0006936) | 5.49650891 |
| 30 | fatty acid transmembrane transport (GO:1902001) | 5.30820551 |
| 31 | glucan biosynthetic process (GO:0009250) | 5.27502683 |
| 32 | glycogen biosynthetic process (GO:0005978) | 5.27502683 |
| 33 | cardiac myofibril assembly (GO:0055003) | 5.23252257 |
| 34 | cytidine deamination (GO:0009972) | 5.12210132 |
| 35 | cytidine metabolic process (GO:0046087) | 5.12210132 |
| 36 | cytidine catabolic process (GO:0006216) | 5.12210132 |
| 37 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.10094703 |
| 38 | muscle fiber development (GO:0048747) | 5.06003535 |
| 39 | muscle system process (GO:0003012) | 4.88595315 |
| 40 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.84569218 |
| 41 | glycogen metabolic process (GO:0005977) | 4.71199181 |
| 42 | carnitine transmembrane transport (GO:1902603) | 4.67031685 |
| 43 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.64357833 |
| 44 | neuronal action potential propagation (GO:0019227) | 4.63194854 |
| 45 | cellular glucan metabolic process (GO:0006073) | 4.61716715 |
| 46 | glucan metabolic process (GO:0044042) | 4.61716715 |
| 47 | regulation of actin filament-based movement (GO:1903115) | 4.52706820 |
| 48 | muscle adaptation (GO:0043500) | 4.52229048 |
| 49 | actomyosin structure organization (GO:0031032) | 4.50174359 |
| 50 | cardiac muscle hypertrophy (GO:0003300) | 4.35997446 |
| 51 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.34617322 |
| 52 | IMP biosynthetic process (GO:0006188) | 4.32501093 |
| 53 | muscle organ morphogenesis (GO:0048644) | 4.32123571 |
| 54 | NADH metabolic process (GO:0006734) | 4.30925029 |
| 55 | negative regulation of skeletal muscle tissue development (GO:0048642) | 4.29802953 |
| 56 | amino-acid betaine transport (GO:0015838) | 4.28551361 |
| 57 | carnitine transport (GO:0015879) | 4.28551361 |
| 58 | response to activity (GO:0014823) | 4.17956443 |
| 59 | 2-oxoglutarate metabolic process (GO:0006103) | 4.17709465 |
| 60 | regulation of cofactor metabolic process (GO:0051193) | 4.17291324 |
| 61 | regulation of coenzyme metabolic process (GO:0051196) | 4.17291324 |
| 62 | striated muscle hypertrophy (GO:0014897) | 4.16642239 |
| 63 | ubiquinone biosynthetic process (GO:0006744) | 4.14153902 |
| 64 | cellular carbohydrate catabolic process (GO:0044275) | 4.11011028 |
| 65 | cellular response to dexamethasone stimulus (GO:0071549) | 4.10801321 |
| 66 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.98314380 |
| 67 | fructose metabolic process (GO:0006000) | 3.90783952 |
| 68 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.90357059 |
| 69 | negative regulation of muscle hypertrophy (GO:0014741) | 3.87297344 |
| 70 | muscle organ development (GO:0007517) | 3.87018222 |
| 71 | neuromuscular synaptic transmission (GO:0007274) | 3.85050015 |
| 72 | regulation of relaxation of muscle (GO:1901077) | 3.83157971 |
| 73 | response to dexamethasone (GO:0071548) | 3.83024554 |
| 74 | muscle structure development (GO:0061061) | 3.82874407 |
| 75 | muscle cell fate commitment (GO:0042693) | 3.80529634 |
| 76 | adult heart development (GO:0007512) | 3.77614690 |
| 77 | ubiquinone metabolic process (GO:0006743) | 3.77056380 |
| 78 | myotube differentiation (GO:0014902) | 3.76886881 |
| 79 | striated muscle cell development (GO:0055002) | 3.74587406 |
| 80 | muscle hypertrophy (GO:0014896) | 3.70133201 |
| 81 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.69189271 |
| 82 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.69189271 |
| 83 | regulation of striated muscle contraction (GO:0006942) | 3.67668815 |
| 84 | muscle tissue morphogenesis (GO:0060415) | 3.66544742 |
| 85 | muscle cell cellular homeostasis (GO:0046716) | 3.66030341 |
| 86 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.60748074 |
| 87 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.60688724 |
| 88 | gluconeogenesis (GO:0006094) | 3.59986293 |
| 89 | otic vesicle formation (GO:0030916) | 3.58423916 |
| 90 | cardiac muscle contraction (GO:0060048) | 3.55883353 |
| 91 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.49054385 |
| 92 | regulation of sulfur metabolic process (GO:0042762) | 3.47213897 |
| 93 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.45480519 |
| 94 | heart contraction (GO:0060047) | 3.43901199 |
| 95 | heart process (GO:0003015) | 3.43901199 |
| 96 | tricarboxylic acid cycle (GO:0006099) | 3.42753517 |
| 97 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.41556374 |
| 98 | intracellular lipid transport (GO:0032365) | 3.36971229 |
| 99 | negative regulation of muscle contraction (GO:0045932) | 3.35786346 |
| 100 | skeletal muscle tissue development (GO:0007519) | 3.35216881 |
| 101 | cardiac muscle cell development (GO:0055013) | 3.34913186 |
| 102 | cellular polysaccharide metabolic process (GO:0044264) | 3.33607878 |
| 103 | quinone biosynthetic process (GO:1901663) | 3.33403789 |
| 104 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.30733632 |
| 105 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.30733632 |
| 106 | regulation of sequestering of triglyceride (GO:0010889) | 3.29883163 |
| 107 | aspartate family amino acid catabolic process (GO:0009068) | 3.27384067 |
| 108 | myoblast fusion (GO:0007520) | 3.26170387 |
| 109 | relaxation of muscle (GO:0090075) | 3.25715193 |
| 110 | positive regulation of myotube differentiation (GO:0010831) | 3.23748724 |
| 111 | AMP metabolic process (GO:0046033) | 3.20854233 |
| 112 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.20375616 |
| 113 | nucleotide salvage (GO:0043173) | 3.19546047 |
| 114 | hexose biosynthetic process (GO:0019319) | 3.19316173 |
| 115 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.18094516 |
| 116 | muscle hypertrophy in response to stress (GO:0003299) | 3.18094516 |
| 117 | cardiac muscle adaptation (GO:0014887) | 3.18094516 |
| 118 | cellular polysaccharide biosynthetic process (GO:0033692) | 3.17664670 |
| 119 | muscle cell development (GO:0055001) | 3.16833554 |
| 120 | neuromuscular junction development (GO:0007528) | 3.16527874 |
| 121 | purine-containing compound salvage (GO:0043101) | 3.13522838 |
| 122 | polysaccharide biosynthetic process (GO:0000271) | 3.12293047 |
| 123 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.11146248 |
| 124 | positive regulation of cation channel activity (GO:2001259) | 3.09469465 |
| 125 | endoplasmic reticulum organization (GO:0007029) | 3.09134113 |
| 126 | polysaccharide metabolic process (GO:0005976) | 3.07920083 |
| 127 | positive regulation of myoblast differentiation (GO:0045663) | 3.07206370 |
| 128 | regulation of skeletal muscle contraction (GO:0014819) | 12.5428403 |
| 129 | muscle filament sliding (GO:0030049) | 12.0869162 |
| 130 | actin-myosin filament sliding (GO:0033275) | 12.0869162 |
| 131 | skeletal muscle adaptation (GO:0043501) | 11.1108181 |
| 132 | skeletal muscle contraction (GO:0003009) | 10.9627308 |
| 133 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.6561834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 9.76616100 |
| 2 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.83823159 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.73207828 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.40653251 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.32062677 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.19988289 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.18116917 |
| 8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.83586685 |
| 9 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.75730607 |
| 10 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.75432248 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.56835006 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.43709230 |
| 13 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.41782907 |
| 14 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.41782907 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.34570335 |
| 16 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.28865280 |
| 17 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.14927618 |
| 18 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.94116856 |
| 19 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.90947315 |
| 20 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.89054257 |
| 21 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.82941871 |
| 22 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.82369238 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.79153455 |
| 24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.68963046 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.65660337 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62582724 |
| 27 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.60859982 |
| 28 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.52271169 |
| 29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51111094 |
| 30 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.48476281 |
| 31 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.44607774 |
| 32 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.44139049 |
| 33 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.44005874 |
| 34 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.43994859 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.43179873 |
| 36 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.42384540 |
| 37 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.42009796 |
| 38 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.41320215 |
| 39 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.39706002 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39159811 |
| 41 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38890991 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.38512603 |
| 43 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.37755991 |
| 44 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.37327514 |
| 45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.33649622 |
| 46 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.32492733 |
| 47 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.32282854 |
| 48 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.29881602 |
| 49 | SA1_27219007_Chip-Seq_Bcells_Human | 1.28959138 |
| 50 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.28683216 |
| 51 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27630422 |
| 52 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.24604948 |
| 53 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.24551958 |
| 54 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.24022507 |
| 55 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.23998310 |
| 56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23997845 |
| 57 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.23226861 |
| 58 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.22926368 |
| 59 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.22730554 |
| 60 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.22730554 |
| 61 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21760777 |
| 62 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.21688426 |
| 63 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.20702697 |
| 64 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.19680684 |
| 65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18022992 |
| 66 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17762040 |
| 67 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.17186738 |
| 68 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.16770186 |
| 69 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15902527 |
| 70 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.15270856 |
| 71 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.15197329 |
| 72 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.14021149 |
| 73 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.13971990 |
| 74 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.13765975 |
| 75 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.12398121 |
| 76 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.12027460 |
| 77 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.11450520 |
| 78 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.10407725 |
| 79 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.10058517 |
| 80 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.09716711 |
| 81 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.08094896 |
| 82 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.07531636 |
| 83 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.07290284 |
| 84 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05602426 |
| 85 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.04993513 |
| 86 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.04611229 |
| 87 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.04545772 |
| 88 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04307621 |
| 89 | ATF3_27146783_Chip-Seq_COLON_Human | 1.02946058 |
| 90 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.02936434 |
| 91 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02921252 |
| 92 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02296744 |
| 93 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.02005514 |
| 94 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.01829029 |
| 95 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.01812965 |
| 96 | VDR_22108803_ChIP-Seq_LS180_Human | 1.01614213 |
| 97 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.00870190 |
| 98 | * CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.99327247 |
| 99 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.97885664 |
| 100 | P68_20966046_ChIP-Seq_HELA_Human | 0.96693861 |
| 101 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96651989 |
| 102 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.96352548 |
| 103 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.96187769 |
| 104 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94455249 |
| 105 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94190840 |
| 106 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93927524 |
| 107 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93484382 |
| 108 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.93137761 |
| 109 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92491238 |
| 110 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92440025 |
| 111 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92340553 |
| 112 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92317422 |
| 113 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.91857293 |
| 114 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.91067571 |
| 115 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.90472647 |
| 116 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.90199945 |
| 117 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.89844318 |
| 118 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.88950990 |
| 119 | NFYB_21822215_ChIP-Seq_K562_Human | 0.88564570 |
| 120 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88289479 |
| 121 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.88224632 |
| 122 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.87659276 |
| 123 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87035138 |
| 124 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.86726744 |
| 125 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.85745367 |
| 126 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.85457340 |
| 127 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.85378210 |
| 128 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.85255471 |
| 129 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85016998 |
| 130 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.84863691 |
| 131 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.84819595 |
| 132 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.84739419 |
| 133 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.84526132 |
| 134 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.84029900 |
| 135 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.83900115 |
| 136 | CBP_21632823_ChIP-Seq_H3396_Human | 0.83512658 |
| 137 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.83508895 |
| 138 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.83508895 |
| 139 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83420461 |
| 140 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.83286232 |
| 141 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.83239811 |
| 142 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.83232662 |
| 143 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82576822 |
| 144 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.82565074 |
| 145 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.82444338 |
| 146 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.82245231 |
| 147 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.80827116 |
| 148 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.80664494 |
| 149 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79601836 |
| 150 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.78370623 |
| 151 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.77563733 |
| 152 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.76725789 |
| 153 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.75596217 |
| 154 | NCOR_22424771_ChIP-Seq_293T_Human | 0.75246824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 8.27273294 |
| 2 | MP0003646_muscle_fatigue | 7.35921095 |
| 3 | MP0000749_muscle_degeneration | 6.34828948 |
| 4 | MP0000751_myopathy | 5.55737449 |
| 5 | MP0000747_muscle_weakness | 4.35989861 |
| 6 | MP0002106_abnormal_muscle_physiology | 4.31384045 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.08831288 |
| 8 | MP0000759_abnormal_skeletal_muscle | 3.84255409 |
| 9 | MP0002269_muscular_atrophy | 3.69536622 |
| 10 | MP0005369_muscle_phenotype | 3.54373257 |
| 11 | MP0004087_abnormal_muscle_fiber | 3.33600103 |
| 12 | MP0004130_abnormal_muscle_cell | 3.30859544 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 3.27673862 |
| 14 | MP0000750_abnormal_muscle_regeneration | 3.20858564 |
| 15 | MP0005620_abnormal_muscle_contractility | 3.12646251 |
| 16 | MP0004233_abnormal_muscle_weight | 2.70880721 |
| 17 | MP0000733_abnormal_muscle_development | 2.39393163 |
| 18 | MP0002332_abnormal_exercise_endurance | 2.31358291 |
| 19 | MP0004185_abnormal_adipocyte_glucose | 1.95236374 |
| 20 | MP0006036_abnormal_mitochondrial_physio | 1.90967346 |
| 21 | MP0002108_abnormal_muscle_morphology | 1.86076073 |
| 22 | MP0005330_cardiomyopathy | 1.63609502 |
| 23 | MP0005666_abnormal_adipose_tissue | 1.41376469 |
| 24 | MP0004270_analgesia | 1.40923331 |
| 25 | MP0002971_abnormal_brown_adipose | 1.38124398 |
| 26 | MP0004084_abnormal_cardiac_muscle | 1.34481162 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.30627950 |
| 28 | MP0003221_abnormal_cardiomyocyte_apopto | 1.19495156 |
| 29 | MP0002972_abnormal_cardiac_muscle | 1.12528615 |
| 30 | MP0005266_abnormal_metabolism | 1.11299984 |
| 31 | MP0004484_altered_response_of | 1.10787322 |
| 32 | MP0001661_extended_life_span | 1.10252698 |
| 33 | MP0004215_abnormal_myocardial_fiber | 1.06764321 |
| 34 | MP0010630_abnormal_cardiac_muscle | 1.05448506 |
| 35 | MP0002822_catalepsy | 1.04836667 |
| 36 | MP0005375_adipose_tissue_phenotype | 1.02098319 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 0.92565303 |
| 38 | MP0006035_abnormal_mitochondrial_morpho | 0.91900110 |
| 39 | MP0003950_abnormal_plasma_membrane | 0.87644543 |
| 40 | MP0003656_abnormal_erythrocyte_physiolo | 0.85433422 |
| 41 | MP0002234_abnormal_pharynx_morphology | 0.81174518 |
| 42 | MP0004134_abnormal_chest_morphology | 0.79168264 |
| 43 | MP0000372_irregular_coat_pigmentation | 0.79146558 |
| 44 | MP0009250_abnormal_appendicular_skeleto | 0.79107463 |
| 45 | MP0001544_abnormal_cardiovascular_syste | 0.76570025 |
| 46 | MP0005385_cardiovascular_system_phenoty | 0.76570025 |
| 47 | MP0004085_abnormal_heartbeat | 0.76087109 |
| 48 | MP0000013_abnormal_adipose_tissue | 0.75995609 |
| 49 | MP0002638_abnormal_pupillary_reflex | 0.74326276 |
| 50 | MP0005451_abnormal_body_composition | 0.72388635 |
| 51 | MP0008961_abnormal_basal_metabolism | 0.71302588 |
| 52 | MP0000762_abnormal_tongue_morphology | 0.69965293 |
| 53 | MP0004043_abnormal_pH_regulation | 0.69148361 |
| 54 | MP0005645_abnormal_hypothalamus_physiol | 0.68354816 |
| 55 | MP0001299_abnormal_eye_distance/ | 0.67098228 |
| 56 | MP0004147_increased_porphyrin_level | 0.64626486 |
| 57 | MP0005334_abnormal_fat_pad | 0.64542300 |
| 58 | MP0002078_abnormal_glucose_homeostasis | 0.61814818 |
| 59 | MP0009780_abnormal_chondrocyte_physiolo | 0.59846342 |
| 60 | MP0003137_abnormal_impulse_conducting | 0.59544872 |
| 61 | MP0006276_abnormal_autonomic_nervous | 0.58657761 |
| 62 | MP0002734_abnormal_mechanical_nocicepti | 0.54747481 |
| 63 | MP0000003_abnormal_adipose_tissue | 0.54575951 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 0.54150793 |
| 65 | MP0002127_abnormal_cardiovascular_syste | 0.53725897 |
| 66 | MP0005670_abnormal_white_adipose | 0.52390634 |
| 67 | MP0000266_abnormal_heart_morphology | 0.49595545 |
| 68 | MP0005275_abnormal_skin_tensile | 0.49526887 |
| 69 | MP0010030_abnormal_orbit_morphology | 0.48392972 |
| 70 | MP0003136_yellow_coat_color | 0.47931557 |
| 71 | MP0003011_delayed_dark_adaptation | 0.47680783 |
| 72 | MP0001849_ear_inflammation | 0.47582628 |
| 73 | MP0000579_abnormal_nail_morphology | 0.47339310 |
| 74 | MP0005332_abnormal_amino_acid | 0.46775566 |
| 75 | MP0001529_abnormal_vocalization | 0.44626561 |
| 76 | MP0005452_abnormal_adipose_tissue | 0.44612556 |
| 77 | MP0000343_altered_response_to | 0.44518930 |
| 78 | MP0005423_abnormal_somatic_nervous | 0.44353348 |
| 79 | MP0008775_abnormal_heart_ventricle | 0.42358049 |
| 80 | MP0008872_abnormal_physiological_respon | 0.41910680 |
| 81 | MP0009672_abnormal_birth_weight | 0.41555096 |
| 82 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.40671497 |
| 83 | MP0005083_abnormal_biliary_tract | 0.39775686 |
| 84 | MP0002089_abnormal_postnatal_growth/wei | 0.39090178 |
| 85 | MP0008569_lethality_at_weaning | 0.38708232 |
| 86 | MP0003879_abnormal_hair_cell | 0.38591938 |
| 87 | MP0003959_abnormal_lean_body | 0.37445880 |
| 88 | MP0001346_abnormal_lacrimal_gland | 0.37286084 |
| 89 | MP0002876_abnormal_thyroid_physiology | 0.35400299 |
| 90 | MP0003045_fibrosis | 0.35294302 |
| 91 | MP0002114_abnormal_axial_skeleton | 0.35113798 |
| 92 | MP0004142_abnormal_muscle_tone | 0.33970751 |
| 93 | MP0002896_abnormal_bone_mineralization | 0.33602165 |
| 94 | MP0009115_abnormal_fat_cell | 0.33442545 |
| 95 | MP0002067_abnormal_sensory_capabilities | 0.32140365 |
| 96 | MP0000678_abnormal_parathyroid_gland | 0.32035321 |
| 97 | MP0002796_impaired_skin_barrier | 0.30023901 |
| 98 | MP0001986_abnormal_taste_sensitivity | 0.28811237 |
| 99 | MP0000383_abnormal_hair_follicle | 0.28399174 |
| 100 | MP0002128_abnormal_blood_circulation | 0.28247406 |
| 101 | MP0005319_abnormal_enzyme/_coenzyme | 0.28054297 |
| 102 | MP0001243_abnormal_dermal_layer | 0.27918018 |
| 103 | MP0003941_abnormal_skin_development | 0.27625506 |
| 104 | MP0003828_pulmonary_edema | 0.27518052 |
| 105 | MP0009697_abnormal_copulation | 0.26938129 |
| 106 | MP0006138_congestive_heart_failure | 0.26441114 |
| 107 | MP0002066_abnormal_motor_capabilities/c | 0.26220615 |
| 108 | MP0003948_abnormal_gas_homeostasis | 0.26156265 |
| 109 | MP0003755_abnormal_palate_morphology | 0.25417740 |
| 110 | MP0004510_myositis | 0.25193548 |
| 111 | MP0006292_abnormal_olfactory_placode | 0.25062928 |
| 112 | MP0005376_homeostasis/metabolism_phenot | 0.24997787 |
| 113 | MP0004924_abnormal_behavior | 0.23898337 |
| 114 | MP0000230_abnormal_systemic_arterial | 0.21958262 |
| 115 | MP0003195_calcinosis | 0.21830987 |
| 116 | MP0002118_abnormal_lipid_homeostasis | 0.21611811 |
| 117 | MP0003567_abnormal_fetal_cardiomyocyte | 0.21121152 |
| 118 | MP0005535_abnormal_body_temperature | 0.21072135 |
| 119 | MP0005187_abnormal_penis_morphology | 0.20903975 |
| 120 | MP0005076_abnormal_cell_differentiation | 0.20596299 |
| 121 | MP0002139_abnormal_hepatobiliary_system | 0.19650480 |
| 122 | MP0008770_decreased_survivor_rate | 0.19378162 |
| 123 | MP0003385_abnormal_body_wall | 0.19075225 |
| 124 | MP0002932_abnormal_joint_morphology | 0.17769282 |
| 125 | MP0002109_abnormal_limb_morphology | 0.16556536 |
| 126 | MP0000427_abnormal_hair_cycle | 0.16419357 |
| 127 | MP0001943_abnormal_respiration | 0.16244637 |
| 128 | MP0002970_abnormal_white_adipose | 0.16054892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 9.70392474 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.34089062 |
| 3 | Exercise-induced myalgia (HP:0003738) | 9.26547248 |
| 4 | Nemaline bodies (HP:0003798) | 8.59791417 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 8.42822827 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.20851084 |
| 7 | Distal arthrogryposis (HP:0005684) | 7.07527499 |
| 8 | Myopathic facies (HP:0002058) | 6.85021637 |
| 9 | Type 1 muscle fiber predominance (HP:0003803) | 6.82966526 |
| 10 | Calf muscle hypertrophy (HP:0008981) | 6.25245613 |
| 11 | Round ear (HP:0100830) | 6.13219313 |
| 12 | Ulnar deviation of the wrist (HP:0003049) | 6.06400137 |
| 13 | Difficulty running (HP:0009046) | 5.75625085 |
| 14 | Myoglobinuria (HP:0002913) | 5.52951903 |
| 15 | Calcaneovalgus deformity (HP:0001848) | 5.33719634 |
| 16 | Muscle fiber splitting (HP:0003555) | 5.26538247 |
| 17 | Muscle stiffness (HP:0003552) | 5.17088376 |
| 18 | Absent phalangeal crease (HP:0006109) | 5.05464509 |
| 19 | Deformed tarsal bones (HP:0008119) | 4.78780084 |
| 20 | Rhabdomyolysis (HP:0003201) | 4.68777574 |
| 21 | Hyporeflexia of lower limbs (HP:0002600) | 4.66427610 |
| 22 | Myotonia (HP:0002486) | 4.50414602 |
| 23 | EMG: myopathic abnormalities (HP:0003458) | 4.42516752 |
| 24 | Increased connective tissue (HP:0009025) | 4.39255710 |
| 25 | Abnormal finger flexion creases (HP:0006143) | 4.23621656 |
| 26 | Abnormality of the calf musculature (HP:0001430) | 4.02857478 |
| 27 | Malignant hyperthermia (HP:0002047) | 3.75962441 |
| 28 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.67096889 |
| 29 | Subaortic stenosis (HP:0001682) | 3.63211203 |
| 30 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.63211203 |
| 31 | Rimmed vacuoles (HP:0003805) | 3.53919868 |
| 32 | Pelvic girdle muscle weakness (HP:0003749) | 3.52141398 |
| 33 | Shoulder girdle muscle weakness (HP:0003547) | 3.51877204 |
| 34 | Difficulty climbing stairs (HP:0003551) | 3.47545017 |
| 35 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.39065664 |
| 36 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.39065664 |
| 37 | Increased variability in muscle fiber diameter (HP:0003557) | 3.36986637 |
| 38 | Hyperkalemia (HP:0002153) | 3.35488367 |
| 39 | Neck muscle weakness (HP:0000467) | 3.29974607 |
| 40 | Areflexia of lower limbs (HP:0002522) | 3.19998059 |
| 41 | Abnormality of the calcaneus (HP:0008364) | 3.19496762 |
| 42 | Frequent falls (HP:0002359) | 2.98544850 |
| 43 | Paralysis (HP:0003470) | 2.94060504 |
| 44 | Asymmetric septal hypertrophy (HP:0001670) | 2.78107794 |
| 45 | Bundle branch block (HP:0011710) | 2.68407387 |
| 46 | Abnormality of the neuromuscular junction (HP:0003398) | 2.68108144 |
| 47 | Fatigable weakness (HP:0003473) | 2.68108144 |
| 48 | Muscular dystrophy (HP:0003560) | 2.42972954 |
| 49 | EMG: neuropathic changes (HP:0003445) | 2.41057081 |
| 50 | Hypoplastic ischia (HP:0003175) | 2.39980356 |
| 51 | Sudden death (HP:0001699) | 2.38243875 |
| 52 | Slender build (HP:0001533) | 2.34879404 |
| 53 | Nonprogressive disorder (HP:0003680) | 2.34417920 |
| 54 | Dilated cardiomyopathy (HP:0001644) | 2.33722558 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 2.32752874 |
| 56 | Limb-girdle muscle weakness (HP:0003325) | 2.31377518 |
| 57 | Proximal amyotrophy (HP:0007126) | 2.19061082 |
| 58 | Abnormality of the ischium (HP:0003174) | 2.08876688 |
| 59 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.08188013 |
| 60 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.06237672 |
| 61 | Ulnar deviation of finger (HP:0009465) | 2.04061256 |
| 62 | Generalized muscle weakness (HP:0003324) | 2.03964956 |
| 63 | Facial diplegia (HP:0001349) | 2.01762970 |
| 64 | Metatarsus adductus (HP:0001840) | 2.00323981 |
| 65 | Increased intramyocellular lipid droplets (HP:0012240) | 1.95519493 |
| 66 | Bulbar palsy (HP:0001283) | 1.95016440 |
| 67 | Lipoatrophy (HP:0100578) | 1.94919044 |
| 68 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.94496266 |
| 69 | Gowers sign (HP:0003391) | 1.91751988 |
| 70 | Scapular winging (HP:0003691) | 1.90132106 |
| 71 | Distal lower limb amyotrophy (HP:0008944) | 1.88994970 |
| 72 | Achilles tendon contracture (HP:0001771) | 1.87739434 |
| 73 | Increased density of long bones (HP:0006392) | 1.87277737 |
| 74 | Abnormality of the foot musculature (HP:0001436) | 1.86461649 |
| 75 | Limb-girdle muscle atrophy (HP:0003797) | 1.83514137 |
| 76 | Increased muscle lipid content (HP:0009058) | 1.83507149 |
| 77 | Heart block (HP:0012722) | 1.82994884 |
| 78 | Stridor (HP:0010307) | 1.82942768 |
| 79 | Spinal rigidity (HP:0003306) | 1.82130484 |
| 80 | Hyperuricemia (HP:0002149) | 1.80019214 |
| 81 | Increased purine levels (HP:0004368) | 1.80019214 |
| 82 | Cholelithiasis (HP:0001081) | 1.79927601 |
| 83 | Type 2 muscle fiber atrophy (HP:0003554) | 1.77790079 |
| 84 | Short palpebral fissure (HP:0012745) | 1.76266104 |
| 85 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.75219566 |
| 86 | Weak cry (HP:0001612) | 1.74562142 |
| 87 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.72669159 |
| 88 | Abnormality of the Achilles tendon (HP:0005109) | 1.70859763 |
| 89 | Ragged-red muscle fibers (HP:0003200) | 1.69902865 |
| 90 | Abnormality of potassium homeostasis (HP:0011042) | 1.69562243 |
| 91 | Waddling gait (HP:0002515) | 1.69358936 |
| 92 | Progressive muscle weakness (HP:0003323) | 1.68313770 |
| 93 | Foot dorsiflexor weakness (HP:0009027) | 1.66253346 |
| 94 | Gout (HP:0001997) | 1.65791801 |
| 95 | Tarsal synostosis (HP:0008368) | 1.63426726 |
| 96 | Abnormal atrioventricular conduction (HP:0005150) | 1.62622484 |
| 97 | Muscle fiber atrophy (HP:0100295) | 1.60503779 |
| 98 | Oligomenorrhea (HP:0000876) | 1.59470281 |
| 99 | Abnormal gallbladder morphology (HP:0012437) | 1.59329441 |
| 100 | Lower limb amyotrophy (HP:0007210) | 1.58414621 |
| 101 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.58275263 |
| 102 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.58266369 |
| 103 | Fetal akinesia sequence (HP:0001989) | 1.57720231 |
| 104 | Ventricular tachycardia (HP:0004756) | 1.56265005 |
| 105 | Long clavicles (HP:0000890) | 1.51484855 |
| 106 | Popliteal pterygium (HP:0009756) | 1.48926277 |
| 107 | Synostosis involving bones of the feet (HP:0009140) | 1.47481767 |
| 108 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.47481767 |
| 109 | Toxemia of pregnancy (HP:0100603) | 1.46496588 |
| 110 | Exercise intolerance (HP:0003546) | 1.46096401 |
| 111 | Hypokalemia (HP:0002900) | 1.45865846 |
| 112 | Congenital hip dislocation (HP:0001374) | 1.44404210 |
| 113 | Acute necrotizing encephalopathy (HP:0006965) | 1.43896519 |
| 114 | Wrist flexion contracture (HP:0001239) | 1.43569835 |
| 115 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.41901022 |
| 116 | Adducted thumb (HP:0001181) | 1.40161316 |
| 117 | Hip contracture (HP:0003273) | 1.39266809 |
| 118 | Hyperglycinuria (HP:0003108) | 1.35796499 |
| 119 | Limited hip movement (HP:0008800) | 1.34505887 |
| 120 | Ventricular arrhythmia (HP:0004308) | 1.34324173 |
| 121 | Steppage gait (HP:0003376) | 1.32055638 |
| 122 | Neonatal hypotonia (HP:0001319) | 1.29546837 |
| 123 | Hepatic necrosis (HP:0002605) | 1.29135865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.59157163 |
| 2 | TTN | 6.46528487 |
| 3 | PHKG1 | 5.94677275 |
| 4 | PHKG2 | 5.94677275 |
| 5 | NME1 | 4.61001102 |
| 6 | PIK3CG | 3.42708325 |
| 7 | MAP2K3 | 2.86791412 |
| 8 | NEK1 | 2.43004508 |
| 9 | MAP3K7 | 2.17819994 |
| 10 | PINK1 | 2.09974057 |
| 11 | DMPK | 1.94499639 |
| 12 | MAP2K4 | 1.84485499 |
| 13 | PDK3 | 1.84159467 |
| 14 | PDK4 | 1.84159467 |
| 15 | TRIB3 | 1.64013194 |
| 16 | PIK3CA | 1.57859544 |
| 17 | MAPK12 | 1.57396635 |
| 18 | BCKDK | 1.53782854 |
| 19 | MAP2K6 | 1.41657752 |
| 20 | MUSK | 1.27637352 |
| 21 | LATS1 | 1.26210536 |
| 22 | PDK2 | 1.20629160 |
| 23 | MAP3K6 | 1.09702337 |
| 24 | PRKAA2 | 1.03206760 |
| 25 | TAOK1 | 0.98483164 |
| 26 | NEK9 | 0.97870183 |
| 27 | PRKAA1 | 0.96414191 |
| 28 | LATS2 | 0.92087533 |
| 29 | CCNB1 | 0.89191937 |
| 30 | MAPKAPK3 | 0.88259700 |
| 31 | MARK1 | 0.86486054 |
| 32 | MAP3K3 | 0.82478461 |
| 33 | TAOK2 | 0.82303669 |
| 34 | STK24 | 0.78837719 |
| 35 | TRPM7 | 0.72272900 |
| 36 | BMPR1B | 0.70122556 |
| 37 | KSR2 | 0.68289504 |
| 38 | MAPK11 | 0.67965339 |
| 39 | VRK2 | 0.67504233 |
| 40 | ERBB3 | 0.64548874 |
| 41 | CDK19 | 0.63236970 |
| 42 | STK38L | 0.60664533 |
| 43 | MAP3K11 | 0.60383217 |
| 44 | TNIK | 0.55340926 |
| 45 | DAPK2 | 0.54315097 |
| 46 | CAMK2G | 0.52375839 |
| 47 | CAMK4 | 0.50463816 |
| 48 | AKT2 | 0.49834818 |
| 49 | EEF2K | 0.49140159 |
| 50 | ZAK | 0.49076884 |
| 51 | CAMK2A | 0.47549751 |
| 52 | FRK | 0.46407793 |
| 53 | CAMK1 | 0.44612984 |
| 54 | CAMK2D | 0.42890058 |
| 55 | NUAK1 | 0.39788231 |
| 56 | PKN2 | 0.39396807 |
| 57 | OXSR1 | 0.38561625 |
| 58 | RIPK1 | 0.38000914 |
| 59 | MAP3K5 | 0.37419607 |
| 60 | WNK3 | 0.37194177 |
| 61 | MAP4K2 | 0.36526214 |
| 62 | EPHB1 | 0.35627218 |
| 63 | ILK | 0.35051240 |
| 64 | SIK1 | 0.32791596 |
| 65 | MAP3K1 | 0.32621186 |
| 66 | SGK1 | 0.31477514 |
| 67 | LIMK1 | 0.30977543 |
| 68 | MOS | 0.30646902 |
| 69 | CAMK2B | 0.30456883 |
| 70 | PAK6 | 0.30039343 |
| 71 | INSRR | 0.28262843 |
| 72 | MAP3K13 | 0.28193983 |
| 73 | MAP3K4 | 0.27647734 |
| 74 | ADRBK2 | 0.27186209 |
| 75 | GRK1 | 0.26496832 |
| 76 | RPS6KA3 | 0.26071831 |
| 77 | ERBB4 | 0.25780373 |
| 78 | PRKACB | 0.25350726 |
| 79 | PTK6 | 0.25022643 |
| 80 | PRKG1 | 0.23401407 |
| 81 | PKN1 | 0.21932515 |
| 82 | STK3 | 0.21812563 |
| 83 | RPS6KB1 | 0.21506867 |
| 84 | NLK | 0.17566467 |
| 85 | PRKD3 | 0.17484596 |
| 86 | PRKACA | 0.15877620 |
| 87 | PLK4 | 0.15848965 |
| 88 | SGK2 | 0.15273625 |
| 89 | MAPK7 | 0.14818014 |
| 90 | MAPK4 | 0.14478385 |
| 91 | TYK2 | 0.14149776 |
| 92 | PDPK1 | 0.13810322 |
| 93 | CAMK1G | 0.13774769 |
| 94 | MAP3K10 | 0.13507441 |
| 95 | PRKD1 | 0.13480445 |
| 96 | STK16 | 0.13443207 |
| 97 | VRK1 | 0.12979392 |
| 98 | KSR1 | 0.12068896 |
| 99 | ROCK1 | 0.11808720 |
| 100 | TBK1 | 0.11619370 |
| 101 | RAF1 | 0.11421018 |
| 102 | MAP3K8 | 0.11289126 |
| 103 | TAF1 | 0.11028081 |
| 104 | PDK1 | 0.11015103 |
| 105 | PRKCQ | 0.10977646 |
| 106 | MAPKAPK5 | 0.10795395 |
| 107 | MAP2K1 | 0.10771142 |
| 108 | STK38 | 0.10637938 |
| 109 | MAP3K9 | 0.09997483 |
| 110 | MARK3 | 0.09846425 |
| 111 | PBK | 0.09679862 |
| 112 | CSNK1A1 | 0.09188752 |
| 113 | TNK2 | 0.09147237 |
| 114 | RPS6KA1 | 0.09121345 |
| 115 | CDK8 | 0.08983291 |
| 116 | TIE1 | 0.08504455 |
| 117 | RPS6KA6 | 0.07703831 |
| 118 | MAPK10 | 0.07633929 |
| 119 | CSNK1D | 0.07115848 |
| 120 | TGFBR1 | 0.06732307 |
| 121 | RET | 0.06192571 |
| 122 | GSK3B | 0.05889339 |
| 123 | STK11 | 0.05483047 |
| 124 | SGK3 | 0.05388669 |
| 125 | BMX | 0.05130400 |
| 126 | PRKCA | 0.04975280 |
| 127 | TSSK6 | 0.04903846 |
| 128 | JAK2 | 0.04852986 |
| 129 | MAP2K2 | 0.04755974 |
| 130 | ADRBK1 | 0.04284534 |
| 131 | PNCK | 0.04019965 |
| 132 | MTOR | 0.03631790 |
| 133 | BRAF | 0.00887394 |
| 134 | MAPK13 | 0.00112106 |
| 135 | PRKACG | 0.00082117 |
| 136 | DYRK1B | -0.0244048 |
| 137 | RPS6KB2 | -0.0229549 |
| 138 | LRRK2 | -0.0226962 |
| 139 | MAPK9 | -0.0199290 |
| 140 | PRKDC | -0.0172647 |
| 141 | ABL2 | -0.0156822 |
| 142 | MAPK8 | -0.0075579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.09729360 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.09506330 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.63220324 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.27139221 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.23247413 |
| 6 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 3.17033192 |
| 7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.13108639 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 3.04924978 |
| 9 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.61123668 |
| 10 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.52435493 |
| 11 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.45073602 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.30206687 |
| 13 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.22546792 |
| 14 | Insulin resistance_Homo sapiens_hsa04931 | 2.22517943 |
| 15 | Carbon metabolism_Homo sapiens_hsa01200 | 2.12302621 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.94366498 |
| 17 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.85365137 |
| 18 | Galactose metabolism_Homo sapiens_hsa00052 | 1.85211531 |
| 19 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.84757286 |
| 20 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.77671703 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.73353980 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.60301188 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.59226821 |
| 24 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.58082093 |
| 25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.55462665 |
| 26 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.44703442 |
| 27 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.44586883 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42393009 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.40580336 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.40374370 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.38961922 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.35267414 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.31216175 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.30495336 |
| 35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.29234385 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.27054919 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.25769095 |
| 38 | Tight junction_Homo sapiens_hsa04530 | 1.25074234 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.20945252 |
| 40 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.20605373 |
| 41 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.17192297 |
| 42 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.15365335 |
| 43 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.12547685 |
| 44 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.09304439 |
| 45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.09092016 |
| 46 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.04816147 |
| 47 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.01564975 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01210457 |
| 49 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.99203814 |
| 50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.92619757 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92242301 |
| 52 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.90596167 |
| 53 | Phototransduction_Homo sapiens_hsa04744 | 0.90302971 |
| 54 | Focal adhesion_Homo sapiens_hsa04510 | 0.90235083 |
| 55 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.88866883 |
| 56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.79512123 |
| 57 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77650146 |
| 58 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74041696 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.60425064 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.59052850 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.58895884 |
| 62 | Huntingtons disease_Homo sapiens_hsa05016 | 0.55755902 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55692825 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55338584 |
| 65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48174214 |
| 66 | Long-term depression_Homo sapiens_hsa04730 | 0.47642577 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47253889 |
| 68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47204097 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.45875687 |
| 70 | Olfactory transduction_Homo sapiens_hsa04740 | 0.42542619 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37977731 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37650373 |
| 73 | RNA polymerase_Homo sapiens_hsa03020 | 0.36818777 |
| 74 | Insulin secretion_Homo sapiens_hsa04911 | 0.36511277 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36454259 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33139177 |
| 77 | Histidine metabolism_Homo sapiens_hsa00340 | 0.33034443 |
| 78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.32649125 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.31346970 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31202760 |
| 81 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.29191291 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.27216629 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26673352 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.25365133 |
| 85 | Proteasome_Homo sapiens_hsa03050 | 0.24825041 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24541063 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.24188930 |
| 88 | RNA degradation_Homo sapiens_hsa03018 | 0.22563519 |
| 89 | Purine metabolism_Homo sapiens_hsa00230 | 0.21578648 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.21248418 |
| 91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.20934422 |
| 92 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.20395186 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.20250891 |
| 94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.19752457 |
| 95 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.19652942 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.19124459 |
| 97 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.18931192 |
| 98 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.17968881 |
| 99 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.17891510 |
| 100 | Ribosome_Homo sapiens_hsa03010 | 0.17874195 |
| 101 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.17530427 |
| 102 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.16754607 |
| 103 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.15820286 |
| 104 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.15612048 |
| 105 | Long-term potentiation_Homo sapiens_hsa04720 | 0.14815926 |
| 106 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.13833030 |
| 107 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.13688636 |
| 108 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.11914526 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.11722937 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.11585021 |
| 111 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.11526180 |
| 112 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.11487863 |
| 113 | Basal transcription factors_Homo sapiens_hsa03022 | 0.11436416 |
| 114 | Sulfur relay system_Homo sapiens_hsa04122 | 0.11163916 |
| 115 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.10121192 |
| 116 | Lysine degradation_Homo sapiens_hsa00310 | 0.09599770 |
| 117 | Salivary secretion_Homo sapiens_hsa04970 | 0.09093935 |
| 118 | Peroxisome_Homo sapiens_hsa04146 | 0.07902437 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.07792015 |
| 120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.07657561 |
| 121 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.07453011 |
| 122 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.07403341 |
| 123 | Thyroid cancer_Homo sapiens_hsa05216 | 0.07337161 |
| 124 | Circadian entrainment_Homo sapiens_hsa04713 | 0.06456661 |

